Zoledronic Acid Administration to Metastatic Breast Cancer Patients With Non-symptomatic Bone Lesions
Status: TERMINATED
Study type: INTERVENTIONAL
Conditions: Breast Cancer|Neoplasm Metastasis
Interventions: DRUG: Zoledronic acid
Sponsor: Spanish Breast Cancer Research Group
Collaborators: Novartis